Pharm III (Exam 1) - Mood Stabilizers

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/69

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

70 Terms

1
New cards

high rate of _____________ vs placebo for many mood stabilizers but not for _______________

suicide, lithium

2
New cards

Lithium indication

bipolar

3
New cards

________ is Well absorbed, peak levels occur

•1.5 - 2 hours (____) and

•4 - 4.5 hours (____)

lithium, IR, CR

4
New cards

lithium half life is around ________hrs and is directly related to ________ since it is 95% renally excreted

24, GFR

5
New cards

lithium renal adjustments are needed when CrCl is below _____mL/min and is contraindicated when CrCl is below ________mL/min

60, 30

6
New cards

lithium (like Na) is filtered by the _______________ and 70-80% is reabsorbed in the __________________________

glomerulus, proximal renal tubules

7
New cards

reabsorption of lithium and _________ is competitive

Na

8
New cards

unlike Na, lithium is not further absorbed in the ______________ and the excretion is not facilitated by _____________ diuretics

distal tubules, thiazide

9
New cards

Lithium contraindications

CV, renal, dehydration, hyponatremia, diuretics (not absolute)

10
New cards

lithium toxicity has ____ and _____ Sx that get progresively worse as the levels rise

GI, CNS

11
New cards

NSAIDs and COX2 inhibitors _______________ lithium levels

increase

12
New cards

preferred NSAID for use with Lithium

Sulindac (Clinoril)

13
New cards

ACE/ARBs and CCBs ___________ the levels of lithium

increase

14
New cards

thiazides _____________ the levels of lithium

increase

15
New cards

loops, mannitol, spironolactone, and triamterene can _____________________ the levels of lithium

increase or decrease

16
New cards

methylxanthines (caffeine, theophylline) can ______________ the levels of lithium

decrease

17
New cards

when stopping lithium, decrease over several ____________________ esp w bipolar

weeks to months

18
New cards

lithium is a __________ drug so levels must be obtained ____________ the next dose

NTI, before

19
New cards

target level for lithium depends on the ____________(acute mania, acute depression, maintenance)

indication

20
New cards

Tx of lithium toxicity

lower or stop dose, saline diuretics, dialysis

21
New cards

If patient has a level > 1.5 mEq/L but NO symptoms of toxicity, ___________ level to ensure it was drawn as a trough

re evaluate

22
New cards

avoid lithium in the ________ trimester of pregnancy due to __________ malformations that can occur in infants

first, cardiac

23
New cards

lithium availibility

oral

24
New cards

lithium in ___________________ can cause cardiac arrhythmias, hypoglycemia, diabetes insipidus, thyroid function abnormalities, floppy infant syndrome, neonatal lithium toxicity

2nd-3rd trimester

25
New cards

Anticonvulsant mood stabilizers are available as _______ dosage forms and select medications may also be available as _____________ products

oral, injectable

26
New cards

Valproic Acid BBWs

hepatic failure, pancreatitis

27
New cards

valproic acid is an enzyme _____________

inhibitor

28
New cards

valproic acid can increase the toxicity of ____________

lamotrigine

29
New cards

drugs that lower the concentration of valproic acid

contraceptives, carbapenems, rifampin

30
New cards

valproic acid dosing can be ______________ or ____________

weight based, fixed

31
New cards

there is a poor correlation between serum levels of ____________ and anti manic effects

valproic acid

32
New cards

___________ pts have a decreased elimination of valproic acid so we need to start lower and go slower

elderly

33
New cards

do not use ______________ if planning to become pregnant

valproic acid

34
New cards

________________ can cause congenital malformations and should only be used in pregnancy to manage bipolar disorder if no other effective option exists

valproate

35
New cards

________ auto-induces its own metabolism and that of ________ substrates

CBZ, CYP3A4

36
New cards

REQUIRED for CBZ: Test for _________*1502 in patients at increased risk for developing SCARs, particularly Asian ancestry; if positive, avoid therapy; some guidelines recommend ALL patients be tested

HLA-B

37
New cards

Test for _______*3101 in pts on lithium - if positive, may increase risk of hypersensitivity; guidelines not well-established

HLA-A

38
New cards

CBZ/Oxcarb ADEs

sedation, SIADH, bone marrow suppression, agranulocytosis/aplastic anemia

39
New cards

CBZ/Oxcarb BBW

agranulocytosis/aplastic anemia

40
New cards

Oxcarb may be __________ sedating and have _________ bone marrow toxicity than CBZ

less, less

41
New cards

CBZ/Oxcarb are very potent inducers of ______________

CYP3A4

42
New cards

CBZ/Oxcarb reduced the efficacy of _____________ and select _______________

oral contraceptives, antipsychotics

43
New cards

contraindicated for use with CBZ/Oxcarb due to additive myelosuppressive effects

Clozapine (Clozaril)

44
New cards

CBZ/Oxcarb increases the concentrations of _________________ and the use of both together is contraindicated

Lurasidone (Latuda)

45
New cards

Antipsychotics which may be given but require higher doses when given with ___________: quetiapine, aripiprazole, iloperidone, cariprazine, brexpiprazole

CBZ

46
New cards

once pt is on CBZ therapy for 2-3mo, recheck levels to ensure still in ____________ range as auto induction may lead to __________ levels

therapeutic, decreased

47
New cards

______ can cause congenital malformations and should only be used in pregnancy to manage bipolar disorder if no other effective option exists

CBZ

48
New cards

Associated with SIADH in the elderly

CBZ

49
New cards

•Narrow therapeutic index drug

•Therapeutic drug levels are not routinely monitored for bipolar disorder

•Obtain if symptoms of toxicity arise, suspected non-adherence, new drug interactions, pregnancy, or to establish a patient-specific "efficacy level"

CBZ

50
New cards

Lamotrigine BBW

rash

51
New cards

70% of Topiramate dose is eliminated in ______ as unchanged drug

urine

52
New cards

Topiramate Renal dose adjustment when CrCl is below ___mL/min - reduce dose to ____% of normal dose and titrate more slowly

70, 50

53
New cards

Risk for causing birth defects (cleft lip and palate)

topiramate

54
New cards

Topiramate (Trokendi XR formulation) contraindication

Recent alcohol use (within 6 hours prior to and 6 hours after administration)

55
New cards

Topiramate ADEs

CNS, weight loss, anorexia

56
New cards

oral contraceptives may have _______________ effectiveness when taken w topiramate

decreased

57
New cards

valproic acid and topiramate combo may increase ________________ effects

hepatotoxic

58
New cards

GABA analog ADE

somnolence

59
New cards

GABA analog drug interactions

CNS depressants

60
New cards

Pts should not ________________ taking GABA analogs

abruptly stop

61
New cards

pregabalin controlled class

V

62
New cards

most sedating

CBZ, topiramate

63
New cards

rash most likely

CBZ, lamotrigine

64
New cards

most weight gain

gabapentin, valproic acid

65
New cards

most weight loss

topiramate

66
New cards

Inducers (induce metabolism of other drugs)

CBZ

67
New cards

Inhibitors (inhibit metabolism of other drugs)

valproate

68
New cards

OC failure due to mood stabilizer therapy

increases risk of pregnancy

CBZ, topiramate

69
New cards

Mood stabilizer failure due to oral contraceptive

increases risk of bipolar symptoms

lamotrigine, valproic acid

70
New cards

best for use in pregnancy

lamotrigine